The healthcare industry is poised for growth driven by aging populations, technological advancements, and increased ...

Altria Group reported robust Q4 earnings, driven by NJOY's alternative products growth. Click here to see why MO stock is a ...

Stratasys' stock surged over 20% after the company released preliminary fourth quarter results, even though results were ...

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...

MO stock, with 41% returns since the beginning of 2024, has outperformed the S&P 500 index, up 27%. This can be attributed to the company’s decision to reduce its stake in Anheuser-Busch InBev last ...

Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...

Learn more about whether Alcon Inc. or The Cooper Companies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Foresight's Growth VCTs invested an initial £4.5m in HSL in 2015, which supported the appointment of CEO Dominic Walsh.

Gulick said her company applied for retail and online ... to prevent people under age 21 from seeing his smoking devices. Consumable hemp crackdown already sent smoke shops reeling For him and ...

Altria's Q4 earnings matched expectations, with a $1 billion share buyback authorized and strong sales growth, while ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...